Comparison between Intellius Recode IPO and Manipal Health Enterprises IPO.
Intellius Recode IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Manipal Health Enterprises IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Intellius Recode IPO is up to ₹0.00 Cr whereas the issue size of the Manipal Health Enterprises IPO is up to ₹0.00 Cr. The final issue price of Intellius Recode IPO is and of Manipal Health Enterprises IPO is .
| Intellius Recode IPO | Manipal Health Enterprises IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹117.00 Cr | up to ₹8,000.00 Cr |
| OFS Issue Size | 12,90,000 shares | 4,32,27,668 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Intellius Recode IPO opens on , while Manipal Health Enterprises IPO opens on . The closing date of Intellius Recode IPO and Manipal Health Enterprises IPO is , and , respectively.
Intellius Recode IPO P/E ratio is , as compared to Manipal Health Enterprises IPO P/E ratio of .
| Intellius Recode IPO | Manipal Health Enterprises IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Proforma Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 95 | 81.42 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 110.23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 45.54 | 26.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 110.23 | 18.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Intellius Recode IPO Retail Individual Investors (RII) are offered 0 shares while in Manipal Health Enterprises IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Intellius Recode IPO and 0 shares in Manipal Health Enterprises IPO.
| Intellius Recode IPO | Manipal Health Enterprises IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Intellius Recode IPO subscribed in total, whereas Manipal Health Enterprises IPO subscribed .
